Nonfatal aplastic anemia associated with clopidogrel;Klopidogrel ile iliskili ölümcül olmayan aplastik anemi

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 3, 2010, Pages 291-

  Uz, Ömer ^a   Kardeşoǧlu, Ejder ^a   Aparci, Mustafa ^a   Yiǧiner, Ömer ^a   Işilak, Zafer ^a   Özmen, Namik ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL;

ACUTE CORONARY SYNDROME; ADULT; APLASTIC ANEMIA; BONE MARROW BIOPSY; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; CORONARY STENT; DRUG WITHDRAWAL; EDITORIAL; FATIGUE; HUMAN; LABORATORY DIAGNOSIS; LOADING DRUG DOSE; MALE;

EID: 77954330307     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2010.075     Document Type: Editorial

References (5)

1. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
2. Chemnitz J, Sohngen D, Schulz A, Diehl V, Scheid C. Fatal toxic bone marrow failure associated with clopidogrel. Eur J Haematol 2003; 71: 473-4.
3. Harker LA, Boissel JP, Pilgrim AJ, Gent M. Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. Clopidogrel versus aspirin in patients at risk of ischemic events. Drug Saf 1999; 21: 325-35.
4. Andres E, Perrin AE, Alt M, Goichot B, Schlienger JL. Febrile pancytopenia associated with clopidogrel. Arch Intern Med 2001; 161: 125.
5. Trivier JM, Caron J, Mathieu M, Cambier N, Rose C. Fatal aplastic anemia associated with clopidogrel. Lancet 2001; 357: 446.